Bruker Corporation Stock

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:06 2024-05-16 pm EDT 5-day change 1st Jan Change
75.82 USD -2.18% Intraday chart for Bruker Corporation -0.51% +3.18%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 3.31B Sales 2025 * 3.54B Capitalization 11.02B
Net income 2024 * 336M Net income 2025 * 443M EV / Sales 2024 * 3.54 x
Net Debt 2024 * 706M Net Debt 2025 * 550M EV / Sales 2025 * 3.27 x
P/E ratio 2024 *
34.5 x
P/E ratio 2025 *
25.3 x
Employees 9,707
Yield 2024 *
0.26%
Yield 2025 *
0.26%
Free-Float 55.13%
More Fundamentals * Assessed data
Dynamic Chart
Bruker Keeps Quarterly Dividend at $0.05 Per Share; Payable June 17 to Shareholders of Record on June 3 MT
Bruker Corporation Announces Quarterly Dividend, Payable on June 17, 2024 CI
Bruker's NanoString Secures Patent Case Win in Germany MT
Bruker Corporation completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V. CI
Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance MT
Transcript : Bruker Corporation, Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (BRKR) BRUKER CORPORATION Posts Q1 Revenue $721.7M, vs. Street Est of $729M MT
Earnings Flash (BRKR) BRUKER CORPORATION Reports Q1 EPS $0.53, vs. Street Est of $0.46 MT
Bruker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Bruker Corporation Revises Earnings Guidance for the Year 2024 CI
Bruker Corporation completed the acquisition of ELITech Group SAS from Tecfin S.À R.L. CI
Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference CI
Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies MT
Bruker Corporation entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $390 million. CI
Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating MT
More news
1 day-2.18%
1 week-0.51%
Current month-2.81%
1 month-9.62%
3 months-7.33%
6 months+23.34%
Current year+3.18%
More quotes
1 week
73.85
Extreme 73.85
78.11
1 month
68.89
Extreme 68.89
83.32
Current year
68.66
Extreme 68.66
94.86
1 year
53.79
Extreme 53.79
94.86
3 years
48.42
Extreme 48.42
94.86
5 years
30.78
Extreme 30.78
94.86
10 years
15.78
Extreme 15.778
94.86
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 91-01-31
Director of Finance/CFO 66 16-11-30
Public Communications Contact - 10-09-30
Members of the board TitleAgeSince
Director/Board Member 66 15-08-18
Director/Board Member 77 00-01-31
Director/Board Member 67 15-11-10
More insiders
Date Price Change Volume
24-05-16 75.82 -2.18% 1,498,703
24-05-15 77.51 +2.43% 827,659
24-05-14 75.67 +1.93% 1,077,600
24-05-13 74.24 -1.94% 832,436
24-05-10 75.71 -0.66% 1,007,291

Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT

More quotes
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
75.82 USD
Average target price
85.7 USD
Spread / Average Target
+13.03%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW